476 related articles for article (PubMed ID: 29181621)
1. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.
Živković V; Cvetković T; Mitić B; Stamenković B; Stojanović S; Radovanović-Dinić B; Jurišić V
Rheumatol Int; 2018 Jun; 38(6):1003-1008. PubMed ID: 29181621
[TBL] [Abstract][Full Text] [Related]
2. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
3. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G
Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812
[TBL] [Abstract][Full Text] [Related]
4. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
5. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
Alzawawy A; Zohary M; Ablordiny M; Eldalie M
Int J Rheum Dis; 2009 Dec; 12(4):311-8. PubMed ID: 20374368
[TBL] [Abstract][Full Text] [Related]
6. Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children.
Ghobrial EE; El Hamshary AA; Mohamed AG; Abd El Raheim YA; Talaat AA
Saudi J Kidney Dis Transpl; 2015; 26(3):507-15. PubMed ID: 26022021
[TBL] [Abstract][Full Text] [Related]
7. Serum and Urine Monocyte Chemoattractant Protein-1 as A Markers for Lupus Nephritis.
Abozaid MA; Ahmed GH; Tawfik NM; Sayed SK; Ghandour AM; Madkour RA
Egypt J Immunol; 2020 Jan; 27(1):97-107. PubMed ID: 33180392
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
9. Association of monocyte chemoattractant protein 1 (MCP-1) gene polymorphism with lupus nephritis in Egyptian patients.
Mohammad LA; Atef DM; Abul-Saoud AM
Hum Immunol; 2015 Oct; 76(10):724-8. PubMed ID: 26429331
[TBL] [Abstract][Full Text] [Related]
10. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
11. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
13. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Wong TY; Szeto CY; Li PK; Szeto CC
Arthritis Rheum; 2004 Sep; 50(9):2882-90. PubMed ID: 15457456
[TBL] [Abstract][Full Text] [Related]
14. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients.
Rosa RF; Takei K; Araújo NC; Loduca SM; Szajubok JC; Chahade WH
J Rheumatol; 2012 Oct; 39(10):1948-54. PubMed ID: 22942263
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
Colliard S; Jourde-Chiche N; Clavarino G; Sarrot-Reynauld F; Gout E; Deroux A; Fougere M; Bardin N; Bouillet L; Cesbron JY; Thielens NM; Dumestre-Pérard C
Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037
[TBL] [Abstract][Full Text] [Related]
18. Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis.
Marks SD; Shah V; Pilkington C; Tullus K
Pediatr Nephrol; 2010 Nov; 25(11):2283-8. PubMed ID: 20683619
[TBL] [Abstract][Full Text] [Related]
19. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
Abujam B; Cheekatla S; Aggarwal A
Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of syndecan-1 are associated with renal involvement in patients with systemic lupus erythematosus.
Kim KJ; Kim JY; Baek IW; Kim WU; Cho CS
J Rheumatol; 2015 Feb; 42(2):202-9. PubMed ID: 25512478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
